These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8603033)

  • 1. Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report.
    Norman AW; Bishop JE; Collins ED; Seo EG; Satchell DP; Dormanen MC; Zanello SB; Farach-Carson MC; Bouillon R; Okamura WH
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):13-22. PubMed ID: 8603033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.
    Bishop JE; Collins ED; Okamura WH; Norman AW
    J Bone Miner Res; 1994 Aug; 9(8):1277-88. PubMed ID: 7976510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minireview: vitamin D receptor: new assignments for an already busy receptor.
    Norman AW
    Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses.
    Norman AW; Okamura WH; Hammond MW; Bishop JE; Dormanen MC; Bouillon R; van Baelen H; Ridall AL; Daane E; Khoury R; Farach-Carson MC
    Mol Endocrinol; 1997 Sep; 11(10):1518-31. PubMed ID: 9280067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
    J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors.
    Dormanen MC; Bishop JE; Hammond MW; Okamura WH; Nemere I; Norman AW
    Biochem Biophys Res Commun; 1994 May; 201(1):394-401. PubMed ID: 8198601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N; Dutta A; Ray R
    Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25(OH)2D3.
    Pedrozo HA; Schwartz Z; Rimes S; Sylvia VL; Nemere I; Posner GH; Dean DD; Boyan BD
    J Bone Miner Res; 1999 Jun; 14(6):856-67. PubMed ID: 10352093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor.
    Yamamoto K; Sun WY; Ohta M; Hamada K; DeLuca HF; Yamada S
    J Med Chem; 1996 Jul; 39(14):2727-37. PubMed ID: 8709103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3).
    Norman AW; Bishop JE; Bula CM; Olivera CJ; Mizwicki MT; Zanello LP; Ishida H; Okamura WH
    Steroids; 2002 May; 67(6):457-66. PubMed ID: 11960621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
    Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
    J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia.
    Nemere I; Dormanen MC; Hammond MW; Okamura WH; Norman AW
    J Biol Chem; 1994 Sep; 269(38):23750-6. PubMed ID: 8089147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity.
    Verlinden L; Verstuyf A; Verboven C; Eelen G; De Ranter C; Gao LJ; Chen YJ; Murad I; Choi M; Yamamoto K; Yamada S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R
    J Biol Chem; 2003 Sep; 278(37):35476-82. PubMed ID: 12829710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
    Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.